..., as treatments for placental dysfunction. This review: (1) highlights potential candidate drug targets in the placenta
effectors of improved uteroplacental blood flow, anti-oxidants, heme oxygenase induction, inhibition of HIF, induction of
cholesterol synthesis pathways, increasing insulinlike growth factor ~~~